Sight Sciences, Inc.

For the period ended Sep 30, 2025. Filed Nov 6, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 6, 2025

SGHT$10.75-2.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(in thousands, except share and per share data)

	Three Months Ended September 30,		Nine Months Ended September 30,
	2025	2024	2025	2024
Revenue	$19,906	$20,157	$56,978	$60,792
Cost of goods sold	2,709	3,250	8,100	9,068
Gross profit	17,197	16,907	48,878	51,724
Operating expenses:
Research and development	3,352	4,746	12,169	13,698
Selling, general and administrative	21,750	23,390	70,139	76,629
Total operating expenses	25,102	28,136	82,308	90,327
Loss from operations	(7,905)	(11,229)	(33,430)	(38,603)
Investment income	965	1,454	3,139	4,628
Interest expense	(1,306)	(1,151)	(3,853)	(3,501)
Loss on debt extinguishment	—	—	—	(1,962)
Other (expense) income, net	(2)	26	(118)	(25)
Loss before income taxes	(8,248)	(10,900)	(34,262)	(39,463)
Provision for income taxes	(79)	166	2	198
Net loss and comprehensive loss	$(8,169)	$(11,066)	$(34,264)	$(39,661)
Net loss per share attributable to common stockholders, basic and diluted	$(0.16)	$(0.22)	$(0.66)	$(0.79)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	52,377,805	50,340,603	51,834,063	49,911,655

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.